Fulltext

Quality of reporting of randomised controlled trials of herbal interventions in ASEAN Plus Six Countries: a systematic review

Pratoomsoot C 1 , Sruamsiri R 2 , Dilokthornsakul P 3 , Chaiyakunapruk N 4

Affiliations 

  • 1 Faculty of Public Health, Naresuan University, Phitsanulok, Thailand
  • 2 Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; Department of Population Medicine, Drug Policy Research Group, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA, United States of America
  • 3 Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; Center for Pharmacoepidemiology and Pharmacoeconomic Research and Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States of America
  • 4 Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor, Malaysia; School of Population Health, Public Health Building, University of Queensland, Herston, Australia; School of Pharmacy, University of Wisconsin, Madison, WI, United States of America
PLoS One, 2015;10(1):e108681.
PMID: 25633206 DOI: 10.1371/journal.pone.0108681

Abstract

Many randomised controlled trials (RCTs) of herbal interventions have been conducted in the ASEAN Communities. Good quality reporting of RCTs is essential for assessing clinical significance. Given the importance ASEAN placed on herbal medicines, the reporting quality of RCTs of herbal interventions among the ASEAN Communities deserved a special attention.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications